Research BMS bags first FDA approval for CELMoD franchise with Zenbexus multiple myeloma nodBy Healthcare Propulsion StaffAugust 14, 20260 In a historic breakthrough for targeted protein degradation, Bristol Myers Squibb has secured the first FDA approval for a CELMoD…
